Early administration of tofacitinib in COVID-19 pneumonitis: An open randomised controlled trial.

European journal of clinical investigation(2023)

引用 1|浏览21
暂无评分
摘要
High-dose tofacitinib therapy in patients with COVID pneumonitis is safe and may prevent deterioration to respiratory failure.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要